Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.
about
VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirusDevelopment of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway.Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirusFinding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding proteinCell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particlesA malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine.Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platformIdentification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide DisplayEpitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform.Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence-Coupled Biopanning Platform.Malaria invasion ligand RH5 and its prime candidacy in blood-stage malaria vaccine designPathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses.Display of single-chain variable fragments on bacteriophage MS2 virus-like particles.Controlled integration of gold nanoparticles and organic fluorophores using synthetically modified MS2 viral capsids.Engineering virus-like particles as vaccine platformsSelf-assembled cage-like protein structures.Thermal stability of RNA phage virus-like particles displaying foreign peptidesEvolution of a designed protein assembly encapsulating its own RNA genome.A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo.
P2860
Q28280059-128B2400-28DE-493A-9B75-53CF946332D0Q34472793-75C4E129-834C-4B76-A7FF-36827FBC4E78Q34933721-032265B0-348B-498B-95FD-17B7A2EE9BC2Q34994491-965FCF14-B0AC-4DA7-833B-414684D083ABQ35129862-CC8BC97E-DAC9-4878-AA98-D5B7E59804A4Q35227478-09E57873-0012-4270-A649-82E9A5FF54C8Q35541210-1E01E4B0-D022-4978-8DA5-4B000690A59EQ35591551-B537688F-1342-4724-9D56-8C165E6437D4Q35683634-70DB9216-25B6-4845-849B-8861F17C5F81Q35827034-C8C1CF49-C6A9-4C30-B204-D21488E893FBQ35847627-1DBE3FA1-6FFA-4CC4-B9F9-03B1B62B60C0Q35887367-1B47AEBE-EE1E-4977-853E-BFB1DB8AD869Q36267886-F180711B-C67B-4CF2-AD8C-F6228571B436Q36279158-FAC89EF7-4B1B-4D2F-90FE-EE7036F7464CQ36763808-6294A516-9565-4277-8722-5755510440D9Q37172342-4371B2A9-4231-48EC-8FE5-66D9B14028CDQ38339875-DA39BDB9-18D5-45C0-A95E-17EEBD67F4E2Q42764128-79CB90C4-3021-45B6-A949-5F2DF084B80EQ47253184-DFA9EA41-EAD5-4F74-B612-60051AA35F37Q55264209-43690EC7-3340-4987-99AC-098953408EE0
P2860
Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Peptide epitope identification ...... hage MS2 virus-like particles.
@ast
Peptide epitope identification ...... hage MS2 virus-like particles.
@en
type
label
Peptide epitope identification ...... hage MS2 virus-like particles.
@ast
Peptide epitope identification ...... hage MS2 virus-like particles.
@en
prefLabel
Peptide epitope identification ...... hage MS2 virus-like particles.
@ast
Peptide epitope identification ...... hage MS2 virus-like particles.
@en
P2093
P2860
P1476
Peptide epitope identification ...... hage MS2 virus-like particles.
@en
P2093
Bryce Chackerian
David S Peabody
Jerri do Carmo Caldeira
Julianne Peabody
P2860
P304
P356
10.1016/J.JMB.2011.03.072
P407
P577
2011-04-09T00:00:00Z